$2.24
Today
as of Oct 2, 16:56 ET
Last 30 days
Recent Press Releases & News
Xenetic Biosciences Announces All-Stock Merger with Santersus, Leaving Existing Shareholders with 15% Stake
Micro Cap Xenetic Biosciences Expands Therapeutic Platform With Santersus Acquisition
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
XBIO earnings at a glance
Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±2.5% on average; after the most recent report on May 12, 2026 it moved -3.7%. XBIO beat the consensus EPS estimate in 2 of its last 2 reported quarters. The share price of $2.24 sits near its 52-week low.
Overview
52-week range
$1.87
$14
3% of range
Avg surprise (last 2)
+23.9%
Avg reaction (last 2)
-2.5%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.41 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.20 | — | — | +66.1% | -3.7% | earnings |
| Wed Nov 12, 2025 | Sep/2025 | $-0.33 | — | — | — | — | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.45 | $-0.64 | +29.7% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.59 | $-0.72 | +18.1% | — | -1.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.28 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.83 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.78 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.69 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.69 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.56 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $660,601 | $806,923 | — | $1M | $589,897 | $593,261 | — | $614,243 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-971,690 | $-502,117 | — | $-544,734 | $-724,412 | $-942,409 | — | $-499,473 |
| Net income | $-929,695 | $-456,382 | — | $-509,940 | $-688,703 | $-903,141 | — | $-436,671 |
| EPS (diluted) | $-0.41 | $-0.20 | — | $-0.33 | $-0.45 | $-0.59 | — | $-0.28 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | $7M | $8M | — | — | $5M | $6M | $7M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $7M | $8M | $8M | $5M | $5M | $5M | $7M | $7M |
| Total assets | $7M | $8M | $8M | $5M | $5M | $6M | $7M | $8M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $894,977 | $958,239 | $968,025 | $1M | $903,430 | $667,927 | $894,263 | $1M |
| Total equity | $6M | $7M | $7M | $4M | $4M | $5M | $6M | $7M |
Implied volatility — last 90 days
No IV snapshots yet for XBIO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
XBIO earnings FAQ
How does XBIO stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.5%, up 0 times and down 2 times.